Differences Between Ecstasy-Using and Nonusing Methamphetamine Users

REFERENCES

• Allen , R. , McCann , U. and Ricaurte , G. 1993 . Persistent effects of (+/-)3–4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) on human sleep . Sleep , 16 : 560 – 64 .
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association . 1994 . Diagnostic and Statistical Manual of Mental Disorders. Fourth Ed. (DSM-IV). Washington, D.C : American Psychiatric Association. .
   Google Scholar
• Anglin, M.D.; Hser, Y.-I. & Chou, C.P . 1993 . Reliability and validity of retrospective behavioral self-report by narcotics addicts . Evaluation Review , 17 ( 1 ) : 90 – 107 .
   Google Scholar
• Battaglia , G. , Yeh , S. and DeSouza , E. 1988 . MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons . Pharmacology, Biochemistry and Behavior , 29 : 269 – 74 .
   PubMed Web of Science ®Google Scholar
• Beck , A. , Steer , R. and Garbin , M. 1988 . Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation . Clinical Psychology Review , 8 : 77 – 100 .
   Web of Science ®Google Scholar
• Bolla , K. , McCann , U. and Ricaurte , G. 1998 . Memory impairment in abstinent MDMA (“Ecstasy”) users . Neurology , 51 : 1532 – 37 .
   PubMed Web of Science ®Google Scholar
• Burgess , C. , O'Donohoe , A. and Gill , M. 2000 . Agony and Ecstasy: A review of MDMA effects and toxicity . European Psychiatry , 15 ( 5 ) : 287 – 94 .
   PubMed Web of Science ®Google Scholar
• Chou , C. P. , Hser , Y.-I. and Anglin , M. D. 1996 . Pattern reliability of narcotics addicts' self-reported data: A confirmatory assessment of construct validity and consistency . Substance Use and Misuse , 31 ( 9 ) : 1189 – 1216 .
   PubMed Web of Science ®Google Scholar
• Cohen , R. and Cocores , J. 1997 . Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; “Ecstasy”) . Progress in Neuro-Psychopharmacology and Biological Psychiatry , 21 : 727 – 34 .
   PubMed Web of Science ®Google Scholar
• Community Epidemiological Work Group (CEWG) . 2001 . Epidemiologic Trends in Drug Abuse: Advance Report, June 2001. Washington, D.C. : NIDA (CEWG Publications). .
   Google Scholar
• Croft , R. , Mackay , A. , Mills , A. and Gruzelier , J. 2001 . The relative contributions of Ecstasy and cannabis to cognitive impairment . Psychopharmacology , 153 : 373 – 79 .
   PubMed Web of Science ®Google Scholar
• Curran , H. 2000 . Is MDMA (“Ecstasy”) neurotoxic in humans? An overview of evidence and of methodological problems in research . Neuropsychobiology , 42 ( 1 ) : 34 – 41 .
   PubMed Web of Science ®Google Scholar
• Curran , H. and Travill , R. 1997 . Mood and cognitive effects of +/- 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) . Addiction , 92 : 821 – 31 .
   PubMed Web of Science ®Google Scholar
• Davison , D. and Parrott , A. 1997 . Ecstasy (MDMA) in recreational users: Self-reported psychological and physiological effects . Human Psychopharmacology , 12 : 221 – 26 .
   Web of Science ®Google Scholar
• Drug Abuse Warning Network (DAWN) . 2000 . The DA WN Report: Club Drugs. Washington, D.C. : Office of Applied Studies, SAMHSA. .
   Google Scholar
• Gerra , G. , Zaimovic , A. , Ferri , M. , Zambelli , U. , Timpano , M. , Neri , E. , Marzocchi , G. , Delsignore , R. and Brambilla , F. 2000 . Long-lasting effects of 3,4-methylenedioxymethamphetamine (Ecstasy) on serotonin system function in humans . Biological Psychiatry , 68 : 719 – 25 .
   Google Scholar
• Gerra , G. , Zaimovic , A. , Giucastro , G. , Maestri , D. , Monica , C. , Sartori , R. , Caccavari , R. and Delsignore , R. 1998 . Serotonergic function after 3,4-methylenedioxymethamphetamine (“Ecstasy”) in humans . International Clinical Psychopharmacology , 13 : 1 – 9 .
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank , E. , Daumann , J. , Tuchtenhagen , F. , Pelz , S. , Becker , S. , Kunert , H. , Fimm , B. and Sass , S. 2000 . Impaired cognitive performance in drug free users of recreational Ecstasy (MDMA) . Journal of Neurology, Neurosurgery and Psychiatry , 68 ( 6 ) : 719 – 25 .
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank , E. , Schreckenberger , M. , Sabri , O. , Aring , C. , Thelen , B. , Spitzer , M. , Kovar , K. , Hermie , L. , Buell , U. and Sass , H. 1999 . Neurometabolic effects of psilocybin, 3,4-methylenedioxyamphetamine (MDA) and d-methamphetamine in health volunteers: A double-blind, placebo-controlled PET study with [18]FDG . Neuropsychopharmacology , 20 ( 6 ) : 565 – 81 .
   PubMed Web of Science ®Google Scholar
• Hammersley , R. , Ditton , J. , Smith , I. and Short , E. 1999 . Patterns of Ecstasy user by drug users . British Journal of Criminology , 39 ( 4 ) : 625 – 47 .
   Web of Science ®Google Scholar
• Harries , D. and De Silva , R. 1992 . “Ecstasy” and intracerebral hemorrhage . Scott Medicine Journal , 31 : 150 – 52 .
   Web of Science ®Google Scholar
• Hatzidimitriou , G. , McCann , U. and Ricaurte , G. 1999 . Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-) 3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery . Journal of Neuroscience , 19 ( 12 ) : 5096 – 107 .
   PubMed Web of Science ®Google Scholar
• Hser , Y. I. , Anglin , M. D. and Chou , C. P. 1992 . Reliability of retrospective self-report by narcotics addicts . Psychological Assessment , 4 ( 2 ) : 207 – 13 .
   Google Scholar
• Institute of Medicine (IOM) . 1996 . Pathways of Addiction. Washington, D.C. : National Academy Press. .
   Google Scholar
• Kelly , P. 2000 . Does recreational Ecstasy use cause long-term cognitive problems? . Western Journal of Medicine , 173 ( 2 ) : 129 – 30 .
   PubMedGoogle Scholar
• Kelly , P. , Ritchie , I. , McBean , D. , Sharkey , J. and Olverman , H. 1995 . Enhanced cerebrovascular responsiveness to hypercapnia following depletion of central serotonergic terminals . Journal of Cerebral Blood Flow Metabolism , 15 : 706 – 13 .
   PubMed Web of Science ®Google Scholar
• Klitzman , R. , Pope , H. Jr. and Hudson , J. 2000 . MDMA (“Ecstasy”) abuse and high-risk sexual behaviors among 169 gay and bisexual men . American Journal of Psychiatry , 157 ( 7 ) : 1162 – 64 .
   PubMed Web of Science ®Google Scholar
• Leshner , A. 2000 . A club drug alert . NIDA Notes , 14 ( 6 ) : 3 – 5 .
   Google Scholar
• McCann , U. , Eligulashvili , V. and Ricaurte , G. 2000 . (+/-)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-induced serotonin neurotoxicity: clinical studies . Neuropsychobiology , 42 ( 1 ) : 11 – 6 .
   PubMed Web of Science ®Google Scholar
• McCann , U. , Mertl , M. , Eligulashvili , V. and Ricaurte , G. 1999 . Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) users: A controlled study . Psychopharmacology , 143 : 417 – 25 .
   PubMed Web of Science ®Google Scholar
• McKay , J. and Weiss , R. 2001 . A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups . Evaluation Review , 25 ( 2 ) : 113 – 61 .
   PubMed Web of Science ®Google Scholar
• Morgan , M. 2000 . Ecstasy (MDMA): A review of its possible persistent psychological effects . Psychopharmacology , 152 : 230 – 48 .
   PubMed Web of Science ®Google Scholar
• Morgan , M. 1999 . Memory deficits associated with recreational use of “Ecstasy” (MDMA) . Psychopharmacology , 141 : 30 – 36 .
   PubMed Web of Science ®Google Scholar
• Morgan , M. 1998 . Lasting psychological sequelae of recreational use of MDMA (“Ecstasy”): controlled studies in humans . Journal of Psychopharmacology , 12 : 101 – 02 .
   Google Scholar
• Obert , J. , McCann , M. , Marinelli-Casey , P. , Weiner , A. , Minsky , S. , Brethen , P. and Rawson , R. 2000 . The Matrix Model of outpatient stimulant abuse treatment: History and description . Journal of Psychoactive Drugs , 32 ( 2 ) : 157 – 64 .
   PubMed Web of Science ®Google Scholar
• Obrocki , J. , Buchert , R. , Väterlein , O. , Thomasius , R. , Beyer , W. and Schiemann , T. 1999 . Ecstasy—long-term effects on the human central nervous system revealed by positron emission tomography . British Journal of Psychiatry , 175 : 186 – 88 .
   PubMed Web of Science ®Google Scholar
• Parrott , A. , Sisk , E. and Turner , J. 2000 . Psychobiological problems in heavy “Ecstasy” (MDMA) polydrug users . Drug and Alcohol Dependence , 60 ( 1 ) : 105 – 10 .
   PubMed Web of Science ®Google Scholar
• Pedersen , W. and Skrondal , A. 1999 . Ecstasy and new patterns of drug use: A normal population study . Addiction , 94 ( 11 ) : 1695 – 1706 .
   PubMed Web of Science ®Google Scholar
• Rawson , R. 1999 . Treatment for Stimulant Use Disorders. Rockville, Maryland : U.S. Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration. . Treatment Improvement Protocol Series 33
   Google Scholar
• Reneman , L. , Booij , J. , Schmand , B. , Schmand , B. , Brink , W. and Gunning , B. 2000 . Memory disturbances in “Ecstasy” users are correlated with an altered brain serotonin neurotransmission . Psychopharmacology , 148 : 322 – 24 .
   PubMed Web of Science ®Google Scholar
• Ricaurte , G. , McCann , U. , Szabo , Z. and Scheffel , U. 2000 . Toxicodynarics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) . Toxicology Letters , 112 : 143 – 46 .
   PubMed Web of Science ®Google Scholar
• Rodgers , J. 2000 . Cognitive performance amongst recreational users of “Ecstasy.” . Psychopharmacology , 151 ( 1 ) : 19 – 24 .
   PubMed Web of Science ®Google Scholar
• Schifano , F. , Di Furia , L. , Forza , G. , Minicuci , N. and Bricolo , R. 1998 . MDMA (“Ecstasy”) consumption in the context of poly drug use: A report of 150 patients . Drug and Alcohol Dependence , 52 : 85 – 90 .
   PubMed Web of Science ®Google Scholar
• Schreckenberger , M. , Gouzoulis-Mayfrank , E. , Sabri , O. , Aming , C. , Zimny , M. , Zeggel , T. , Wagenknecht , G. , Kaiser , H. , Sass , H. and Buell , U. 1999 . “Ecstasy”-induced psychopathology: An 18-FDG PET study . European Journal of Nuclear Medicine , 26 ( 12 ) : 1572 – 79 .
   PubMedGoogle Scholar
• Stocker , S. 2000 . Overall teen drug use stays level, use of MDMA and steroids increases . NIDA Notes , 15 ( 1 ) : 5
   Google Scholar
• Topp , L. , Hando , J. , Dillon , P. , Roche , A. and Solowij , N. 1999 . Ecstasy use in Australia: Patterns of use and associated harm . Drug and Alcohol Dependence , 55 : 105 – 15 .
   PubMed Web of Science ®Google Scholar
• Verkes , R. , Gijsman , H. , Pieters , M. , Schoemaker , R. , Visser , S. , Kuijpers , M. , Pennings , E. , de Bruin , D. , Van de Wijngaart , G. , Van Gerven , J. and Cohen , A. 2001 . Cognitive performance and serotonergic function in users of Ecstasy . Psychopharmacology , 153 : 196 – 202 .
   PubMed Web of Science ®Google Scholar
• Vollenweider , F. , Gamma , A. , Liechti , M. and Huber , T. 1998 . Psychological and cardiovascular effects and short-term sequelae of MDMA (“Ecstasy”) in MDMA-naïve health volunteers . Neuropsychopharmacology , 19 : 241 – 51 .
   PubMed Web of Science ®Google Scholar
• Wareing , M. , Fisk , J. and Murphy , P. 2000 . Working memory deficits in current and previous users of MDMA (“Ecstasy”) . British Journal of Psychology , 91 : 181 – 88 .
   PubMed Web of Science ®Google Scholar
• Zickler , P. 2001 . Annual survey finds increasing teen use of Ecstasy, steroids . NIDA Notes , 16 ( 2 ) : 6
   Google Scholar